FindTrial
Sign In

The Efficacy and Safety of Repeat-dose Potenfill for Temporary Penile Enhancement

A Single-center, Open-label, Long-term, Exploratory Study to Determine the Efficacy and Safety of Repeat-dose Potenfill for Temporary Penile Enhancement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03840070
Enrollment
20
Registered
2019-02-15
Start date
2018-12-17
Completion date
2019-12-30
Last updated
2020-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Penile Enhancement, Penile Girth Enhancement

Brief summary

This clinical study is for small-penis syndrome males who have previously been treated with hyaluronic acid filler for the purpose of increasing their penis. This study will determine the long-term efficacy and safety of Potenfill.

Interventions

DEVICEPotenfill

Maximum: 22ml

Sponsors

Medy-Tox
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Male subjects aged above 19 and below 65. (20≤male≥65) * Subjects will sign an informed consent form

Exclusion criteria

* Prior treatment for penile enhancement (e.g. fat, dermal graft). * Allergic to hyalluronic acid.

Design outcomes

Primary

MeasureTime frameDescription
Subject satisfaction on the penile appearance at 12 months after application of Potenfill12 monthSatisfaction with the physical appearance of penis as assessed by the subject at 12 months after the application of investigational medical device.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026